fasudil has been researched along with Right Ventricular Dysfunction in 4 studies
fasudil: intracellular calcium antagonist; structure in first source
fasudil : An isoquinoline substituted by a (1,4-diazepan-1-yl)sulfonyl group at position 5. It is a Rho-kinase inhibitor and its hydrochloride hydrate form is approved for the treatment of cerebral vasospasm and cerebral ischemia.
Excerpt | Relevance | Reference |
---|---|---|
"Fasudil was well tolerated; one patient discontinued treatment." | 5.42 | Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension. ( Ai, ZS; Gomberg-Maitland, M; He, J; Jiang, R; Jiang, X; Jing, ZC; Liu, D; Wang, L; Yuan, P; Zhao, QH, 2015) |
"Fasudil was well tolerated; one patient discontinued treatment." | 1.42 | Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension. ( Ai, ZS; Gomberg-Maitland, M; He, J; Jiang, R; Jiang, X; Jing, ZC; Liu, D; Wang, L; Yuan, P; Zhao, QH, 2015) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gosal, K | 1 |
Dunlop, K | 1 |
Dhaliwal, R | 1 |
Ivanovska, J | 2 |
Kantores, C | 2 |
Desjardins, JF | 1 |
Connelly, KA | 1 |
McNamara, PJ | 2 |
Jain, A | 1 |
Jankov, RP | 2 |
Jiang, R | 1 |
Ai, ZS | 1 |
Jiang, X | 1 |
Yuan, P | 1 |
Liu, D | 1 |
Zhao, QH | 1 |
He, J | 1 |
Wang, L | 1 |
Gomberg-Maitland, M | 1 |
Jing, ZC | 1 |
Xu, EZ | 1 |
Engelberts, D | 1 |
Kavanagh, BP | 1 |
Yasuda, T | 1 |
Tada, Y | 1 |
Tanabe, N | 1 |
Tatsumi, K | 1 |
West, J | 1 |
4 other studies available for fasudil and Right Ventricular Dysfunction
Article | Year |
---|---|
Rho kinase mediates right ventricular systolic dysfunction in rats with chronic neonatal pulmonary hypertension.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Cyclic Nucleotide Phosphodiesterases, Type 5 | 2015 |
Intravenous fasudil improves in-hospital mortality of patients with right heart failure in severe pulmonary hypertension.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Administration, Intravenous; Adult; Female; Heart Fai | 2015 |
Rescue treatment with a Rho-kinase inhibitor normalizes right ventricular function and reverses remodeling in juvenile rats with chronic pulmonary hypertension.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Age Factors; Aging; Amides; Animals; Apoptosis; Cell | 2010 |
Rho-kinase inhibition alleviates pulmonary hypertension in transgenic mice expressing a dominant-negative type II bone morphogenetic protein receptor gene.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Acute-Phase Proteins; Animals; Blotting, Western; Bon | 2011 |